These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21287675)

  • 1. Role of the interleukin 24 in patients with ulcerative colitis.
    Camarillo GF; Furuzawa-Carballeda J; Martínez-Benítez B; Barreto-Zúñiga R; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2011 Oct; 17(10):2209-10. PubMed ID: 21287675
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin 21 expression is increased in rectal biopsies from patients with ulcerative colitis.
    Yamamoto-Furusho JK; Miranda-Pérez E; Fonseca-Camarillo G; Sánchez-Muñoz F; Barreto-Zuñiga R; Dominguez-Lopez A
    Inflamm Bowel Dis; 2010 Jul; 16(7):1090. PubMed ID: 19998455
    [No Abstract]   [Full Text] [Related]  

  • 3. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT; Li Y; Zhao D; Shen J; Xu XT; Qiao YQ; Zhu MM; Wang TR; Cui Y; Ai LY; Ran ZH
    Inflamm Bowel Dis; 2015 Feb; 21(2):241-50. PubMed ID: 25545374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 17 gene and protein expression are increased in patients with ulcerative colitis.
    Fonseca-Camarillo G; Mendivil EJ; Furuzawa-Carballeda J; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2011 Oct; 17(10):E135-6. PubMed ID: 21761512
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene expression of carnitine organic cation transporters 1 and 2 (OCTN) is downregulated in patients with ulcerative colitis.
    Yamamoto-Furusho JK; Mendivil EJ; Villeda-Ramírez MA; Fonseca-Camarillo G; Barreto-Zuñiga R
    Inflamm Bowel Dis; 2011 Oct; 17(10):2205-6. PubMed ID: 21910182
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantification of low expressed SCD1 gene in colonic mucosa from patients with active ulcerative colitis.
    Bueno-Hernández N; Dominguez-López A; Barreto-Zuñiga R; Sánchez Muñoz F; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2011 Dec; 17(12):E155. PubMed ID: 21898701
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene expression of solute carrier family 9 (sodium/hydrogen exchanger) 3, (SLC9A3) is downregulated in patients with ulcerative colitis.
    Fonseca-Camarillo G; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2012 Jun; 18(6):1197-8. PubMed ID: 22447429
    [No Abstract]   [Full Text] [Related]  

  • 8. High gene expression of CXCL8 is associated with the presence of extraintestinal manifestations and long-term disease in patients with ulcerative colitis.
    Fonseca-Camarillo G; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2013 Feb; 19(2):E22-3. PubMed ID: 22223513
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential expression of occludin in patients with ulcerative colitis and healthy controls.
    Yamamoto-Furusho JK; Mendivil EJ; Fonseca-Camarillo G
    Inflamm Bowel Dis; 2012 Oct; 18(10):E1999. PubMed ID: 22134947
    [No Abstract]   [Full Text] [Related]  

  • 10. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of discs large homolog 5 gene (DLG5) in ulcerative colitis patients compared to healthy individuals.
    Yamamoto-Furusho JK; Mendivil EJ; Fonseca-Camarillo G; Villeda-Espinoza MA; Barreto-Zuñiga R
    Inflamm Bowel Dis; 2011 Jul; 17(7):1639. PubMed ID: 21674725
    [No Abstract]   [Full Text] [Related]  

  • 12. Preserved Na(+)/H(+) exchanger isoform 3 expression and localization, but decreased NHE3 function indicate regulatory sodium transport defect in ulcerative colitis.
    Yeruva S; Farkas K; Hubricht J; Rode K; Riederer B; Bachmann O; Cinar A; Rakonczay Z; Molnár T; Nagy F; Wedemeyer J; Manns M; Raddatz D; Musch MW; Chang EB; Hegyi P; Seidler U
    Inflamm Bowel Dis; 2010 Jul; 16(7):1149-61. PubMed ID: 20027604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional analysis of left-sided colitis, pancolitis, and ulcerative colitis-associated dysplasia.
    Bjerrum JT; Nielsen OH; Riis LB; Pittet V; Mueller C; Rogler G; Olsen J
    Inflamm Bowel Dis; 2014 Dec; 20(12):2340-52. PubMed ID: 25358065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
    Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis.
    Gan HT; Chen YQ; Ouyang Q
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1016-24. PubMed ID: 15955209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease.
    Beltrán CJ; Núñez LE; Díaz-Jiménez D; Farfan N; Candia E; Heine C; López F; González MJ; Quera R; Hermoso MA
    Inflamm Bowel Dis; 2010 Jul; 16(7):1097-107. PubMed ID: 20014018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
    PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
    Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
    Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
    Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.